- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The differentiation syndrome related to amlodipine requires urgent identification and treatment, hyperbilirubinemia is mostly benign but requir...
Ensidipine is the first targeted drug for IDH2 mutant AML, with clear efficacy, but high vigilance is needed for differentiation syndrome, elev...
Vosevi requires strict adherence to specific storage conditions to ensure stable drug efficacy, while patients should pay attention to drug int...
Vosevi is suitable for specific hepatitis C virus (HCV) infected patients, and medication for this special population needs to be adjusted acco...
The storage of Bedaquiline requires strict control of temperature and humidity conditions, and special attention should be paid to cardiac toxi...
Japanese vitamin C (Cinal) is usually well tolerated at regular doses, but excessive or long-term use may cause side effects such as digestive ...
Enqutinib is a multi-target tyrosine kinase inhibitor used for NTRK fusion positive solid tumors and ROS1 positive non-small cell lung cancer. ...
Entretinib is used for NTRK fusion positive solid tumors and ROS1 positive NSCLC, and the following three types of adverse reactions should be ...
Entretinib is an oral multi-target tyrosine kinase inhibitor used for NTRK fusion positive solid tumors and ROS1 positive non-small cell lung c...
Entretinib is a multi-target tyrosine kinase inhibitor used to treat NTRK fusion positive solid tumors and ROS1 positive non-small cell lung ca...
